Advanced search
Publication Cover
Current Medical Research and Opinion Volume 26, 2010 - Issue 1
Submit an article Journal homepage
185
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Switching from oral extended-release methylphenidate to the methylphenidate transdermal system: continued attention-deficit/hyperactivity disorder symptom control and tolerability after abrupt conversion

L.E. Arnold The Ohio State University, Columbus, OH, USACorrespondence[email protected]
,
D.R. Bozzolo The Ohio State University, Columbus, OH, USA
,
P. Hodgkins Shire Development, Inc., Wayne, PA, USA
,
M. McKay Shire Development, Inc., Wayne, PA, USA
,
L. Beckett-Thurman IPS Research Company, Oklahoma City, OK, USA
,
M. Greenbaum Capstone Clinical Research, Libertyville, IL, USA
,
O. Bukstein University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
&
A. Patel PCSD-Feighner Research, San Marcos, CA, USA
 show all
Pages 129-137 | Accepted 24 Oct 2009, Published online: 16 Nov 2009

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Josephine Elia, Zoe Wilson, Lilly Sehgal La Porta, Sibel A Algon, Matthew L Prowler, Shanique T Cartwright, Patricia A McKenna, Seth Laracy, Toshinobu Takeda & Karin Borgmann-Winter. (2011) Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorder. Expert Review of Clinical Pharmacology 4:3, pages 311-328.
Read now

Articles from other publishers (9)

Christoph U. Correll, Brittney R. Starling & Michael Huss. (2021) Systematic review of transdermal treatment options in attention-deficit/hyperactivity disorder: implications for use in adult patients. CNS Spectrums, pages 1-13.
Crossref
Cellina Ching, Guy D. Eslick & Alison S. Poulton. (2019) Evaluation of Methylphenidate Safety and Maximum-Dose Titration Rationale in Attention-Deficit/Hyperactivity Disorder. JAMA Pediatrics 173:7, pages 630.
Crossref
Ronald SteingardSarper TaskiranDaniel F. ConnorJohn S. MarkowitzMark A. Stein. (2019) New Formulations of Stimulants: An Update for Clinicians. Journal of Child and Adolescent Psychopharmacology 29:5, pages 324-339.
Crossref
Ole Jakob Storebø, Nadia Pedersen, Erica Ramstad, Maja Laerke Kielsholm, Signe Sofie Nielsen, Helle B Krogh, Carlos R Moreira-Maia, Frederik L Magnusson, Mathilde Holmskov, Trine Gerner, Maria Skoog, Susanne Rosendal, Camilla Groth, Donna Gillies, Kirsten Buch Rasmussen, Dorothy Gauci, Morris Zwi, Richard Kirubakaran, Sasja J Håkonsen, Lise Aagaard, Erik Simonsen & Christian Gluud. (2018) Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies. Cochrane Database of Systematic Reviews.
Crossref
Robert L. Findling & Steven Dinh. (2014) Transdermal Therapy for Attention-Deficit Hyperactivity Disorder with the Methylphenidate Patch (MTS). CNS Drugs 28:3, pages 217-228.
Crossref
Lise Aagaard. 2014. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions 1 25 .
David Coghill, Tobias Banaschewski, Alessandro Zuddas, Antonio Pelaz, Antonella Gagliano & Manfred Doepfner. (2013) Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies. BMC Psychiatry 13:1.
Crossref
Andrew Lloyd, Paul Hodgkins, Rahul Sasane, Ron Akehurst, Edmund J.S. Sonuga-Barke, Patrick Fitzgerald, Annabel Nixon, Haim Erder & John Brazier. (2011) Estimation of Utilities in Attention-Deficit Hyperactivity Disorder for Economic Evaluations. The Patient: Patient-Centered Outcomes Research 4:4, pages 247-257.
Crossref
Manfred Döpfner, Dieter Breuer, Daniel Walter & Aribert Rothenberger. (2011) An observational study of once-daily modified-release methylphenidate in ADHD: the effect of previous treatment on ADHD symptoms, other externalising symptoms and quality-of-life outcomes. European Child & Adolescent Psychiatry 20:S2, pages 277-288.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.